Yüklüyor......
Statin tolerability: In defence of placebo-controlled trials
BACKGROUND: Statin intolerance is a barrier to effective lipid-lowering treatment. A significant number of patients stop prescribed statins, or can take only a reduced dose, because of adverse events attributed to the statin, and are then considered statin-intolerant. METHODS: Examination of differe...
Kaydedildi:
| Yayımlandı: | Eur J Prev Cardiol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847124/ https://ncbi.nlm.nih.gov/pubmed/26318980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2047487315602861 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|